Professor, Internal Medicine, Washington University School of Medicine
Hematology
Dr. George J. Broze Jr., MD
|
|
Give Review
George Broze is an expert in the field of Hematology. He went to University of Washington School of Medicine. He received awards:"Elected Member". George Broze is a published MD. He published 18 publications, including: 'An acquired, calcium-dependent, factor X inhibitor.' He accepts all Medicare patients.
Publications
- An acquired, calcium-dependent, factor X inhibitor.
- Protein Z, protein Z-dependent protease inhibitor (serpinA10), and the acute-phase response.
- Tissue factor pathway inhibitor: structure-function.
- TFPI? is the GPI-anchored TFPI isoform on human endothelial cells and placental microsomes.
- Inhibition of antithrombin by Plasmodium falciparum histidine-rich protein II.
- Heparin is a major activator of the anticoagulant serpin, protein Z-dependent protease inhibitor.
- The Kunitz-3 domain of TFPI-alpha is required for protein S-dependent enhancement of factor Xa inhibition.
- Kinetic characterization of the protein Z-dependent protease inhibitor reaction with blood coagulation factor Xa.
- Protein Z-dependent protease inhibitor deficiency produces a more severe murine phenotype than protein Z deficiency.
- Substitution of the Gla domain in factor X with that of protein C impairs its interaction with factor VIIa/tissue factor: lack of comparable effect by similar substitu...
- Thrombin-activatable fibrinolysis inhibitor deficiency attenuates bleomycin-induced lung fibrosis.
- Role for the Kunitz-3 domain of tissue factor pathway inhibitor-alpha in cell surface binding.
- Formation of factors IXa and Xa by the extrinsic pathway: differential regulation by tissue factor pathway inhibitor and antithrombin III.
- Glycosyl phosphatidylinositol anchorage of tissue factor pathway inhibitor.
- Lethal perinatal thrombosis in mice resulting from the interaction of tissue factor pathway inhibitor deficiency and factor V Leiden.
- Thrombin-activatable fibrinolysis inhibitor (TAFI) deficient mice.
- Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life.
Schools
University of Washington
University Of Nc Hosps
Doctors Specialties
- Internal Medicine
- Hematology
Accepted Insurances
Awards
- Elected Member
Education
-
University of North Carolina Hospitals -
University of Washington School of Medicine
Hospital
-
Barnes-Jewish Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Jeffrey P. Ward, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael J. Bolger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James M. Epstein, MD |
|
Dr. K D. Riew, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Charles S. Eby, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Emily S. Popovic, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael H. Tomasson, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Mark J. Fesler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James G. Glauber, MD |
|
|
Dr. Gregg E. Davies, MD |
|
|
Dr. Jason J. Li, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jose M. Pacheco, MD |
|
|
Dr. Kristen M. Sanfilippo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carl O. Deetz, MD
This Doctor is OpenDoctor Recommended.
|